Diagnosis and treatment of pediatric psoriasis: current and future (Q38107168)

29 August 2017

title

Diagnosis and treatment of pediatric psoriasis: current and future (English)

1 reference

29 August 2017

Kara N Shah

1

1 reference

29 August 2017

publication date

1 June 2013

1 reference

American Journal of Clinical Dermatology

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

3

1 reference

29 August 2017

page(s)

195-213

1 reference

Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Incidence of psoriasis in children: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

A comparative study of pediatric onset psoriasis with adult onset psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Psoriasiform napkin dermatitis—a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Infantile psoriasis: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Psoriatic juvenile idiopathic arthritis: a tale of two subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Epidemiology of psoriatic arthritis in the population of the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Epidemiology and comorbidity of psoriasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Association between pediatric psoriasis and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

The association of psoriasis and elevated blood lipids in overweight and obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

HLA-C and guttate psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

PSORS2 is due to mutations in CARD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

The genetics of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Environmental Risk Factors in Pediatric Psoriasis: A Multicenter Case–Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

A case of guttate psoriasis following Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Psoriasiform skin lesion and supprative acrodermatitis associated with Kawasaki disease followed by the treatment with infliximab: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Association of psoriasis-like eruption and Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Adult skin disease in the pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Childhood psoriasis: a clinical review of 1262 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Psoriasis in children. A short review and a survey of 245 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Management of childhood psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Therapies for childhood psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

The histopathologic spectrum of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Trends in pediatric psoriasis outpatient health care delivery in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Pediatric psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Management of Pediatric Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Efficacy and safety of treatments for childhood psoriasis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Childhood psoriasis treatment: evidence published over the last 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Therapeutic Moisturizers as Adjuvant Therapy for Psoriasis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Topical tacrolimus in the treatment of inverse psoriasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Results of Goeckerman Treatment for Psoriasis in Children: A 21-Year Retrospective Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Phototherapy in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Treatments for psoriasis and the risk of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Generalized pustular psoriasis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Generalized pustular psoriasis in a 6-week-old infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Congenital erythrodermic psoriasis: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Acitretin is a safe treatment option for infantile pustular psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Juvenile generalized pustular psoriasis: Letters to the editor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Annular pustular psoriasis--most common form of pustular psoriasis in children: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Childhood generalized pustular psoriasis: successful treatment with isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Juvenile generalized pustular psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Erythrodermic psoriasis in childhood. A young Negro child treated with methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Low dose cyclosporin A treatment in generalized pustular psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

The safety profile of biologic therapies for juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Successful treatment of pediatric psoriasis with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Successful treatment of severe psoriatic arthritis with infliximab in an 11-year-old child suffering from linear psoriasis along lines of Blaschko.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Analysis of phenotypic variation in psoriasis as a function of age at onset and family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Etanercept for the treatment of severe childhood psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Psoriasis of early and late onset: A clinical and epidemiologic study from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0026-8

Antistreptococcal interventions for guttate and chronic plaque psoriasis.

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001976

Identifiers

DOI

10.1007/S40257-013-0026-8

1 reference

Dimensions Publication ID

29 August 2017

1044385282

0 references

1 reference